Suchergebnisse - "CADTH therapeutic review"

PubPharm (21)

1

New drugs for type 2 diabetes : second-line therapy -- science report

Erschienen: Ottawa, CADTH, September 2017

CADTH therapeutic review - volume 4, no. 1b

2

Third-line drugs for type 2 diabetes -- project protocol

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, 2017 Aug

CADTH therapeutic review - vol. 5, no. 1a

3

Drugs for chronic hepatitis C infection : cost-effectiveness analysis

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, January 2016

CADTH therapeutic review - volume 3, issue 1C

von Wong, W. | Krahn, M. | Lee, K. | +1

4

Drugs for chronic hepatitis C infection : clinical review

Erschienen: Ottawa, Ontario, Canadian Agency for Drugs and Technologies in Health, January 2016

CADTH therapeutic review - volume 3, issue 1B

von Wells, G.

5

Anti-vascular endothelial growth factor drugs for retinal conditions : a therapeutic review

Erschienen: Ottawa, Canadian Agency for Drugs and Technologies in Health, July 2015

CADTH therapeutic review - volume 3, issue 2a

6

Drugs for pulmonary arterial hypertension : comparative efficacy, safety, and cost-effectiveness : recommendations report

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, March 2015

CADTH therapeutic review report

7

Drugs for pulmonary arterial hypertension : comparative efficacy, safety, and cost-effectiveness

Erschienen: Ottawa, Ontario, Canadian Agency for Drugs and Technologies in Health, March 2015

CADTH therapeutic review report

von Tran, K.

8

Drugs for chronic hepatitis C infection : recommendations report

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, November 2015

CADTH therapeutic review - volume number 3, issue number 1D

Version 1.0.

9

Drugs for chronic hepatitis C infection : project protocol

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, April 2015

CADTH therapeutic review report - vol. 3, issue 1A

10

Recommendations for direct-acting antiviral agents for chronic hepatitis C genotype 1

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, October 2014

CADTH therapeutic review - volume 2, issue 2C